Colorectal cancer (“CRC”) is the second most common cause of cancer death in the UAE. Several experienced sales professionals recently hired to enable broader adoption by additional GI physician groups.Ĭompany appointed diagnostics industry leader Jack Kenny (former CEO of Meridian Biosciences) to Biomerica’s board of directors, bringing a wealth of commercial experience and relationships in the medical diagnostic industry with insights that will be invaluable for the launch of inFoods IBS both domestically and internationally.Īnnounced that the Dubai government has officially approved insurance reimbursement for the EZ Detect product providing qualified Dubai residents access to government-paid at-home screening to detect an early warning sign of colorectal cancer and other colorectal diseases. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the first quarter of fiscal 2024 ended August 31, 2023.Ĭompletes pre-launch phase of inFoods IBS, which remains on track for national market launch during calendar 2024. 13, 2023 (GLOBE NEWSWIRE) - Biomerica, Inc. GAAP gross margin percentage of 24.1% for the first fiscal quarter of 2024 improved substantially over -3.4% for the first fiscal quarter of 2023Ĭompany completes pre-launch phase for inFoods IBS veteran Vice President of sales and national accounts hired along with regional key account representatives Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the first fiscal quarter of 2023Ĭompany believes current cash position, forecasted revenue growth and corporate strategy is expected to enable it to achieve profitability

Sec shorts youtube